Philips CPAP Cancer Lawsuit News

Ozone Cleaning Products Are Not FDA Approved And May Be Responsible For CPAP Foam Insulation Breakdown

Philips is recommending that customers and patients do not use ozone cleaning products on sleep apnea machines

Friday, November 12, 2021 - Healthline.com tell their reader that cleaning one's sleep apnea machine regularly is absolutely essential. Dirt and dust become trapped as air circulates through the machine and can breed bacteria and sickness. "Ozone is effective, but is not authorized by the Food and Drug Administration (FDA)Trusted Source to clean CPAP machines." Hundreds of Phillips CPAP lawsuits allege that a design defect in the sleep apnea machines caused them to breathe toxic chemicals and develop lung cancer and other lesser lung ailments. The Phillips CPAP recall is for several popular models of the CPAP sleep apnea breathing machines because a component of the machine had been compromised. "The polyester-based polyurethane (PE-PUR) sound abatement foam, which is used to reduce sound and vibration in these affected devices, may break down and potentially enter the device's air pathway. If this occurs, black debris from the foam or certain chemicals released into the device's air pathway may be inhaled or swallowed by the person using the device," according to the FDA. Healthline thinks that it would be safer to use UV light or approved disinfecting tablets dissolved in solution to clean a sleep apnea machine.

Royal Phillips, the maker of the DreamStation CPAP device and others, has denied responsibility for any design defect that allegedly caused their foam abatement to deteriorate and give off toxic, carcinogenic particles, chemicals, and gasses to enter the device airway and be inhaled by the user of the sleep apnea device. The company says that the recall is being done out of an abundance of caution so that the situation can be studied before passing judgment. Also, the company thinks an unapproved ozone cleaning solution manufactured by SoClean Inc., is responsible for compromising the insulation foam's integrity. Phillips writes about the cause of foam degradation. "The (recall) notification informs customers and users of potential impacts on patient health and clinical use related to this issue. Possible health risks include exposure to degraded sound abatement foam, for example, caused by unapproved cleaning methods such as ozone, and exposure to chemical emissions from the foam material. High heat and high humidity environments may also contribute to foam degradation in certain regions." Phillips has initiated a campaign to replace the sound abatement foam with a material that will not be affected. Phillips admits that the toxic discharge from the sleep apnea device could cause respiratory distress and infection, headaches, and kidney and liver problems. The company acknowledges the complaints of customers that claim to have found black particles in their airway and say the chemical debris has caused "headache/dizziness, irritation (eyes, nose, respiratory tract, skin), hypersensitivity, nausea/vomiting, toxic and carcinogenic effects." the toxic and carcinogenic effects are assumed to be lung cancer. Phillips says they have not received any reports of serious injuries from using the sleep apnea device and those who rely on it for life support should continue to use the machine."">

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.